The principle guiding drug use states that the therapeutic benefit should outweigh which of the following?

• A. Cost
• B. Risk Of Adverse Effects
• C. Regulatory Hurdles
• D. Patient Satisfaction

Answer: (B)

The main idea here is balancing benefit against risk when deciding to use a drug. The key question is whether the therapeutic benefit a patient is likely to gain from the drug is greater than the potential harm from adverse effects. This risk–benefit assessment guides prescribing: if the expected benefit clearly outweighs the risks, the drug is appropriate; if the risks outweigh or are not justified by the benefit, it’s not.

Think about how favorable a treatment is for the specific patient and condition. The magnitude and certainty of the benefit matter, as do the seriousness, frequency, and reversibility of possible adverse effects. Patient values and alternatives also play a role—sometimes a drug with notable risks can be justified if it tackles a life-threatening disease and has a substantial, well-supported benefit.

Why the other factors aren’t the primary guide: cost influences access and affordability but does not determine whether the pharmacologic risk-benefit balance justifies use; regulatory hurdles concern how a drug gets approved rather than clinical decision-making about its use; patient satisfaction is an outcome but not the core criterion for deciding if a drug should be prescribed.